NCT03395548View on ClinicalTrials.gov

Stability of the Microbiome in IBD and IBS

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

May 1, 2020

Study Completion Date

May 1, 2020

Conditions
Microbiota
Interventions
DRUG

Macrogol

Used drug: Macrogol (osmotic laxative)

Trial Locations (1)

8010

Universitätsklinikum Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT03395548 - Stability of the Microbiome in IBD and IBS | Biotech Hunter | Biotech Hunter